(Q37965727)

26 August 2017

title

Bacterial ghosts as carriers of protein subunit and DNA-encoded antigens for vaccine applications (English)

1 reference

26 August 2017

Abbas Muhammad

1

1 reference

26 August 2017

Jonathan Champeimont

2

1 reference

26 August 2017

Ulrike Beate Mayr

3

1 reference

26 August 2017

Werner Lubitz

4

1 reference

26 August 2017

Pavol Kudela

5

1 reference

26 August 2017

publication date

1 January 2012

1 reference

Expert Review of Vaccines

26 August 2017

published in

1 reference

26 August 2017

volume

11

1 reference

26 August 2017

issue

1

1 reference

26 August 2017

page(s)

97-116

1 reference

Bacterial ghosts as vaccine candidates for veterinary applications.

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Inactivated and subunit vaccines to prevent shigellosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Unmet needs in modern vaccinology: adjuvants to improve the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Immunoprophylaxis against important virus disease of horses, farm animals and birds

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Exploiting cholera vaccines as a versatile antigen delivery platform

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Analysis of strategies to successfully vaccinate infants in developing countries against enterotoxigenic E. coli (ETEC) disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Principles of vaccine design-Lessons from nature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

DNA vaccines: recent developments and future possibilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Direct gene transfer into mouse muscle in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

DNA vaccines and their applications in veterinary practice: current perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

DNA vaccination in the avian

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

The application of nucleic acid vaccines in veterinary medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Immunobiology of muscle: advances in understanding an immunological microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Immunological capabilities of skeletal muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

DNA-loaded bacterial ghosts efficiently mediate reporter gene transfer and expression in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

DNA vaccines: immunology, application, and optimization*

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Liposomal vaccine delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Lipid-based drug delivery systems for cancer treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Liposome-encapsulated doxorubicin (Doxil) and doxorubicin in the treatment of vaccine-associated sarcoma in cats

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Evaluation of a novel tumor vaccine in dogs with hemangiosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Evaluation of particle uptake in human blood monocyte-derived cells in vitro. Does phagocytosis activity of dendritic cells measure up with macrophages?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

DiC14-amidine cationic liposomes stimulate myeloid dendritic cells through Toll-like receptor 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Combination adjuvants: the next generation of adjuvants?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Immunotherapeutic uses of CpG oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

CpG motifs in bacterial DNA and their immune effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Enhancement of human immunodeficiency virus type 1-DNA vaccine potency through incorporation of T-helper 1 molecular adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Genetic adjuvants for DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Efficacy of an infectious hematopoietic necrosis (IHN) virus DNA vaccine in Chinook Oncorhynchus tshawytscha and sockeye O. nerka salmon

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Immunologic responses to West Nile virus in vaccinated and clinically affected horses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Investigation of antigen specific lymphocyte responses in healthy horses vaccinated with an inactivated West Nile virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Development of a xenogeneic DNA vaccine program for canine malignant melanoma at the Animal Medical Center.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Plasmid-mediated growth hormone-releasing hormone efficacy in reducing disease associated with Mycoplasma hyopneumoniae and porcine reproductive and respiratory syndrome virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Immunologic basis of vaccine vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Bacterial ghosts--biological particles as delivery systems for antigens, nucleic acids and drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Extended recombinant bacterial ghost system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Bacterial ghosts: non-living candidate vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Applications of bacterial ghosts in biomedicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Bacterial ghosts as drug carrier and targeting vehicles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Dynamics of PhiX174 protein E-mediated lysis of Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Bacterial ghosts as adjuvant particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

The Bacterial Ghost platform system: production and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Recombinant Vibrio cholerae ghosts as a delivery vehicle for vaccinating against Chlamydia trachomatis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

A Vibrio cholerae ghost-based subunit vaccine induces cross-protective chlamydial immunity that is enhanced by CTA2B, the nontoxic derivative of cholera toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Intramuscular immunization with genetically inactivated (ghosts) Actinobacillus pleuropneumoniae serotype 9 protects pigs against homologous aerosol challenge and prevents carrier state

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Comparative immunogenicity of the hepatitis B virus core 149 antigen displayed on the inner and outer membrane of bacterial ghosts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Bacterial ghosts as an oral vaccine: a single dose of Escherichia coli O157:H7 bacterial ghosts protects mice against lethal challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Bacterial ghosts as a delivery system for zona pellucida-2 fertility control vaccines for brushtail possums (Trichosurus vulpecula).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Evaluation of a broadly protective Chlamydia-cholera combination vaccine candidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Phi X174 protein E-mediated lysis of Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Biochemical characterization of phi X174-protein-E-mediated lysis of Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Bacterial ghosts as antigen delivery vehicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Bacterial ghosts as carrier and targeting systems for mucosal antigen delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Inactivation of DNA by beta-propiolactone

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Escherichia coli ghost production by expression of lysis gene E and Staphylococcal nuclease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

A recombinant multivalent combination vaccine protects against Chlamydia and genital herpes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Bacterial ghosts as carrier and targeting systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Construction of recombinant S-layer proteins (rSbsA) and their expression in bacterial ghosts--a delivery system for the nontypeable Haemophilus influenzae antigen Omp26.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Antigen discovery and delivery of subunit vaccines by nonliving bacterial ghost vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Sequence analysis of the sbsA gene encoding the 130-kDa surface-layer protein of Bacillus stearothermophilus strain PV72.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Effectiveness of engineering the nontypeable Haemophilus influenzae antigen Omp26 as an S-layer fusion in bacterial ghosts as a mucosal vaccine delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Immobilization of plasmid DNA in bacterial ghosts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Effective gene transfer to melanoma cells using bacterial ghosts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Bacterial ghosts as novel efficient targeting vehicles for DNA delivery to the human monocyte-derived dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Improved production and purification of minicircle DNA vector free of plasmid bacterial sequences and capable of persistent transgene expression in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Bacterial ghosts as novel advanced drug delivery systems: antiproliferative activity of loaded doxorubicin in human Caco-2 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Bacterial Ghosts as antigen and drug delivery system for ocular surface diseases: Effective internalization of Bacterial Ghosts by human conjunctival epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Bacterial ghosts as a novel advanced targeting system for drug and DNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Induction of protective immunity by aerosol or oral application of candidate vaccines in a dose-controlled pig aerosol infection model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Iron-regulated lysis of recombinant Escherichia coli in host releases protective antigen and confers biological containment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Generation of Helicobacter pylori ghosts by PhiX protein E-mediated inactivation and their evaluation as vaccine candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Induction of immune memory by a multisubunit chlamydial vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Development of a Chlamydia trachomatis bacterial ghost vaccine to fight human blindness

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Mucosal immunization against respiratory bacterial pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Endotoxicity does not limit the use of bacterial ghosts as candidate vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Recent developments in fish vaccinology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Gut immunology in fish: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Generation of Vibrio anguillarum ghost by coexpression of PhiX 174 lysis E gene and staphylococcal nuclease A gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Gonadotropin-releasing hormone/human chorionic gonadotropin beta based recombinant antibodies and vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Development of a highly immunogenic recombinant candidate vaccine against human chorionic gonadotropin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Deletion and fusion analysis of the phage phi X174 lysis gene E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Genetic analysis of MraY inhibition by the phiX174 protein E

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Mice orally vaccinated with Edwardsiella tarda ghosts are significantly protected against infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

Escherichia coli ghosts promote innate immune responses in human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.149

21 January 2018

Identifiers

DOI

10.1586/ERV.11.149

1 reference

26 August 2017

1 reference